Aben Minerals Logo.png
Aben Minerals Executes a Purchase and Sale Agreement
July 23, 2024 18:30 ET | Aben Minerals
Vancouver, BC, July 23, 2024 (GLOBE NEWSWIRE) -- Aben Minerals Ltd. (TSX-V: ABM) (OTCQB: ABNAF) (Frankfurt: R26) (“Aben” or “the Company”) is pleased to announce the Company has entered into a...
LEM_Logo_Horizontal.png
LEADING EDGE CLOSES FIRST TRANCHE OF PRIVATE PLACEMENT
July 23, 2024 18:00 ET | Leading Edge Materials Corp.
LEADING EDGE MATERIALS CLOSES FIRST TRANCHE OF PRIVATE PLACEMENT Vancouver, July 23, 2024 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North:...
MFL_logo.jpg
Mawson Finland Files Final Prospectus in Connection with IPO
July 23, 2024 14:34 ET | Mawson Finland Limited
Not for distribution to United States newswire services or for dissemination in the United States. TORONTO, July 23, 2024 (GLOBE NEWSWIRE) -- Mawson Finland Limited (“Mawson Finland” or the...
rio_silver_jpg.jpg
Rio Silver Completes Agreement with Local Community at Jorimina Project, Peru
July 23, 2024 09:15 ET | Rio Silver, Inc.
VANCOUVER, British Columbia, July 23, 2024 (GLOBE NEWSWIRE) -- Rio Silver Inc. (“Rio Silver” or the “Company”) (TSX.V: RYO) is pleased to announce it has finalized a surface access agreement (“the...
enwave.jpg
EnWave Signs Commercial License with Royalty Partner for Future Production in Central America
July 23, 2024 09:00 ET | EnWave Corporation
VANCOUVER, British Columbia, July 23, 2024 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a commercial license (the...
Kane Logo Cropped TransBG.png
Kane Biotech Receives FDA Approval to Increase Dosage Allowance of its revyve™ Antimicrobial Wound Gel
July 23, 2024 08:30 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, July 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that the US Food and Drug Administration (FDA)...
Cannara Biotech publ
Cannara Biotech publie ses résultats financiers pour le troisième trimestre de 2024
July 23, 2024 08:30 ET | Cannara Biotech (Québec) Inc.
Les produits bruts du cannabis avant les taxes d’accise ont augmenté pour atteindre 26,2 millions de dollars au troisième trimestre 2024, contre 20,6 millions de dollars au troisième trimestre 2023,...
Cannara Biotech Repo
Cannara Biotech Reports Q3 2024 Financial Results
July 23, 2024 08:30 ET | Cannara Biotech (Québec) Inc.
Net revenues up 22.6% to $19.5M, positive Adjusted EBITDA of $2.8M and operating cash flows of $4.3 million. Focused on the Canadian Cannabis Opportunity
ARHT Logo 2023.png
ARHT Returns to the 3M Open with Interactive Holographic Experience in Minnesota
July 23, 2024 08:30 ET | ARHT Media Inc.
TORONTO, July 23, 2024 (GLOBE NEWSWIRE) -- ARHT Media Inc. ("ARHT" or "the Company") (TSXV: ART), (OTCQB: ARHTF) the global leader in the development, production, and distribution of high-quality,...
solaralliance.jpg
Solar Alliance signs agreements for multiple commercial solar projects totaling $775,000 as mid-sized project momentum accelerates
July 23, 2024 08:00 ET | Solar Alliance Energy Inc.
TORONTO and KNOXVILLE, Tenn., July 23, 2024 (GLOBE NEWSWIRE) -- Solar Alliance Energy Inc. (‘Solar Alliance’ or the ‘Company’) (TSX-V: SOLR, OTC: SAENF), a leading solar energy solutions provider...